Citizen in a RepublicNH Bill Briefing
← All bills

SB 455 · 2026 · Senate · Health and Human Services Committee

Medicaid coverage for GLP-1 medications

AI-generated

(New Title) relative to coverage for GLP-1 medication under the state Medicaid plan.

Directs the department of health and human services to cover GLP-1 medication under the state Medicaid plan when medically necessary for certain health conditions.AI-generated

Status

Killed in the House — Inexpedient to Legislate · May 14, 2026
  1. ✓Introduced
  2. ✓Senate
  3. ✕House
  4. Governor
  5. Law

Analysis

This bill directs the department of health and human services to provide coverage for GLP-1 medication under the state Medicaid plan if such medication is medically necessary for a patient based on certain health conditions.

From the bill's official ANALYSIS section.

In the bill's words

Quoted verbatim from the bill as amended by the Senate. Passages chosen from the operative text.Computed by this site

“Medical assistance under the state Medicaid plan shall include coverage for GLP-1 medication if a health care provider licensed in the state of New Hampshire has determined that such medication is medically necessary for the patient and the patient meets one or more of the following:”
RSA 167:3-n
“The department of health and human services shall submit to CMS any amendment to the state Medicaid plan necessary for implementation no later than January 1, 2027.”
RSA 167:3-n

Official record

Bill page — docket & status

gc.nh.gov · the authoritative source

Sponsors

Sen. Suzanne PrentissDPrimeAssistant Democratic Leader

Public testimony

20 signed in online · 5 wrote testimony

95% support0% oppose5% neutral

In their wordsVerbatim, exactly as submitted

“Type II diabetes is more prevalent in low income groups. Untreated diabetes resulting in serious complications including vascular diseases, kidney failure, loss of eyesight, and comorbidities including obesity, heart disease and hypertension cost so much more than the GLP-1 medications that mitigate and prevent them.…”
— Janet Lucas, Camptonsupports
“My name is Joseph Zucchi, PA-C, and I am a Physician Associate and Clinical Supervisor at Transition Medical Weight Loss in Salem, New Hampshire.…”
— Joseph Zucchi, Salemsupports
“I support SB 455 because it establishes clear, medically grounded criteria for GLP-1 coverage and prevents insurers from using opaque or inconsistent rules to deny evidence-based treatment.…”
— Hannah Meiselman, Manchestersupports
“Dear House Commerce and Consumer Affairs Committee, I am pleased to share a Policy Research Shop brief that my students researched and wrote over the winter term at Dartmouth College providing a cost-benefit analysis of GLP-1 coverage for obesity in New Hampshire.…”
— Kristin Smith, Hanoverneutral

Verbatim excerpts of submitted testimony, quoted from the testimony tool.

Read the testimony · as of Aug 12, 2026

Votes

yeanay
Starting text: Bill as introduced
  • Mar 5, 2026SenateCommittee report: Ought to Pass with Amendment # 2026-0836s5–0
    Overall
    100% yea
  • Mar 5, 2026SenateVoice voteCommittee amendment 2026-0836sadopted
  • Mar 5, 2026SenateVoice voteOught to Pass with Amendment #2026-0836sadopted
    Resulting text: Bill as amended by the Senate
  • Apr 29, 2026HouseCommittee report· regular calendar: Inexpedient to Legislate13–2
    Overall
    87% yea
  • May 14, 2026HouseVoice voteInexpedient to Legislateadopted

Hearings and debates

  • Feb 11, 2026Public hearingSenate Health and Human Services4:15:50–4:18:052m 15slocated in the stream transcriptHearing
  • Mar 5, 2026Floor debateSenate floorWatchnot located in the transcript — opens the full streamCommittee Report: Ought to Pass with Amendment # 2026-0836s; Ought to Pass with Amendment #2026-0836s — adopted, voice vote; Committee Amendment # 2026-0836s — adopted, voice vote
  • Apr 15, 2026Public hearingHouse Commerce and Consumer Affairs1:44:47–1:54:249m 37slocated in the stream transcriptPublic Hearing
  • Apr 22, 2026Public hearingHouse Commerce and Consumer Affairs19:29–20:371m 8slocated in the stream transcriptSubcommittee Work Session
  • Apr 29, 2026Public hearingHouse Commerce and Consumer AffairsWatchnot located in the transcript — opens the full streamCommittee Report: Inexpedient to Legislate — roll call; Executive Session
  • May 14, 2026Floor debateHouse floor17:57–19:251m 28slocated in the stream transcriptInexpedient to Legislate — adopted, voice vote

Timestamps locate where this bill is taken up in the chamber's YouTube stream.

Legislative history

  1. Jan 7, 2026SenIntroduced 01/07/2026 and Referred to Health and Human Services; SJ 1
  2. Feb 11, 2026SenHearing: 02/11/2026, Room 100, SH, 01:00 pm; SC 5
  3. Mar 5, 2026Sen: Ought to Pass with Amendment # 2026-0836s, 03/05/2026; Vote 5-0; CC; SC 8
  4. Mar 5, 2026SenCommittee Amendment # 2026-0836s, AA, VV; 03/05/2026; SJ 5
  5. Mar 5, 2026SenOught to Pass with Amendment #2026-0836s, MA, VV; OT3rdg; 03/05/2026; SJ 5
  6. Mar 12, 2026HouseIntroduced (in recess of) 03/12/2026 and referred to Commerce and Consumer Affairs HJ 8 P. 114
  7. Apr 15, 2026HousePublic Hearing: 04/15/2026 10:30 am GP 229
  8. Apr 22, 2026HouseSubcommittee Work Session: 04/22/2026 10:00 am GP 229
  9. Apr 29, 2026HouseExecutive Session: 04/29/2026 10:00 am GP 229
  10. Apr 29, 2026House: Inexpedient to Legislate 04/29/2026 (Vote 13-2; RC) HC 19 P. 17
  11. May 14, 2026HouseInexpedient to Legislate: MA VV 05/14/2026 HJ 13 P. 26

Coverage

No reporting linked yet.

Documents (PDF)

Bill text & amendments link direct to gc.nh.gov; committee reports stream from the state record.